Skip to main content
Log in

69. und 70. Sitzung der vorläufigen Kommission für kosmetische Mittel am 18. November 2004 und 28. April 2005 in Berlin

  • Tagungsbericht
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. COLIPA–Empfehlung Nr. 13: Anwendungshinweise bei Sonnenschutzmitteln. Deutsche Übersetzung/IKW, März 2004

  2. The SCCNFP’S Notes of Guidance for Testing of Cosmetic Ingredients and their Safety Evaluation, 5th Revision, Okt 2003, Auszug, S 72–78

  3. Dubbert W (2004) Nanotechnologie – Risiken oder Chancen? UMID März UBA, Berlin, S 16–19

  4. Possible adverse health, environmental and safety impacts: Nanoscience and nanotechnologies, July 2004, S 35–50

  5. Oberdörster G et al. (2004) Tanslocation of inhalated ultrafine particles to the brain. Inhalation Toxicol 16: 437–445

    Article  Google Scholar 

  6. SCCP (2005) Request for a scientific opinion: safety of nanomaterials in cosmetic products

    Google Scholar 

  7. SCCNFP/0649/03: Opinion concerning ZINC OXIDE, Colipa n0 S 76, Adopted by the SCCNFP during the 24th plenary meeting of 24–25 June 2003

  8. Weigmann HJ, Lademann J, Pelchrzim R v. et al. (2000) Quantitative Bestimmung des Penetrationsverhaltens von Sonnenschutz- und Arzneimitteln in Relation zum realen Hornschichtprofil. Akt Dermatol 26: 138–141

    Google Scholar 

  9. Lademann J, Weigmann HJ, Rickmeyer C et al. (1999) Penetration of titanium dioxide. Skin Pharmacol Appl Skin Physiol 12: 47–256

    Article  Google Scholar 

  10. Lademann J, Otberg N, Richter H et al. (2003) Follikuläre Penetration. Hautarzt 54: 321–323

    PubMed  Google Scholar 

  11. Hostynek J, Maibach H (2002) Tin, zinc and selenium: metals in cosmetics and personal care products. Cosmetics Toiletries Magazine 117(9)

  12. SCCNFP: Opinion concerning Ketoconazole adopted by the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers during the plenary of 23 June 1999

  13. SCCNFP/0601/02, final: Opinion concerning Ketoconazole, adopted by the SCCNFP during the 21th Plenary Meeting of 17 September 2002

  14. SCCNFP/0706/03, final, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products intended for Consumers concerning azole antimycotic resistance, adopted by the SCCNFP during the 24th Plenary Meeting of 24–25 June 2003

  15. 05/ENTR/COS/27: Ketoconazole Request from DG Enterprise for a CHMP Opinion on various questions, CHMP Report, London, Doc.Ref.: EMEA/CHMP/62096/2005, 17 February 2005

  16. Problematik der Entwicklung von Resistenzen humaner Mykosen gegenüber Azol-Antimykotika und eventueller Wechselwirkungen mit den als Fungizid eingesetzten Pflanzenschutzmitteln, Bericht des BgVV vom 7.6.2001, http://www.bfr.bund.de/cm/218/problematik_der_entwicklung_von_resistenzen_humaner_mykosen_gegenueber_azol_antimykotika.pdf

  17. Gebhardt M, Geier J et al. (1996) Kontaktallergie auf Prothesenkunststoffe und Differentialdiagnostik der Prothesenintoleranz. Dtsch Zahnärztl Z 51: 395–397

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Schulz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulz, C. 69. und 70. Sitzung der vorläufigen Kommission für kosmetische Mittel am 18. November 2004 und 28. April 2005 in Berlin. Bundesgesundheitsbl. 49, 687–692 (2006). https://doi.org/10.1007/s00103-006-1289-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-006-1289-5

Navigation